How to use the speech recognition tool?

Skin-to-Eye Study

Type: Interventional



Status of the trial: Inactive

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2021-01-01
  • Closing Date: 0000-00-00

Criteria

Inclusion: age ≥ 18 ans Participants aux essais cliniques ProQR en cours (InSight (PQ-110-002), Illuminate (PQ-110-003), STELLAR (PQ-421a-001), Futures études cliniques ciblant l’IRD sponsorisées par ProQR Therapeutics) ainsi que d’autres donneurs

Exclusion: cf protocole

Children: No

Adults: Yes

Funder Type: private

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: